A subscription to JoVE is required to view this content. Sign in or start your free trial.
1Experimental Metabolism and Clinical Research Laboratory & Regenerative Medicine and Tissue Engineering Laboratory, 2Hemodynamics Unit, Cardiology Department,Centro Médico Nacional “20 de Noviembre” ISSSTE, 3Laboratorio de Biología del Desarrollo y Teratogénesis Experimental,Hospital Infantil de México Federico Gómez
Chapters
- 00:04Introduction
- 01:26Circulating Mononuclear Progenitor Cell (MPC) Determination
- 04:03Plasma Soluble Biomarker Determination
- 07:39Results: Representative Coronary Progenitor Cell and Soluble Biomarker Analyses Before and After Coronary Angioplasty
- 09:01Conclusion
Development of major adverse cardiovascular events, which impact cardiovascular prognosis after coronary angioplasty, are influenced by the extent of coronary damage and vascular repair. The use of novel coronary cellular and soluble biomarkers, reactive to vascular damage and repair, are useful to predict the development of MACEs and prognosis.
